On October 6, 2022, the Patented Medicine Prices Review Board (PMPRB) published its Draft price regulatory Guidelines and has invited stakeholders to comment on its approach by December 5, 2022.
 
PDCI strives to support timely transparency around public policy consultations and invites organizations and individuals who provided comments to PMPRB to share their submissions here so ideas may be openly shared among interested stakeholders. PDCI will post the consultation responses received here on PDCI’s website. Please note that PDCI will post responses as they are received. Posting your response to this page prior to the consultation deadline may allow others to reference your submission. 

To participate, please e-mail Veronique Scott, Policy Manager, at veronique.scott@pdci.ca with a PDF version of your response including consent for PDCI to publish the response on its website. 

Note: PMPRB intends to make the written submissions publicly available on its website after the closing of the consultation. However, timing for this is not yet clear. Once PMPRB publishes the comprehensive set of submissions, PDCI’s sharing page will direct visitors to the comprehensive set of submissions on the PMPRB website.